Pay in 4 interest-free payments of $7.23 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Benefits of Retatrutide Therapy Unprecedented Weight Loss Early phase trials (NEJM 2023) showed average weight loss of ~24% at 48 weeks, which rivals bariatric surgery outcomes
As the dose climbs, the balance changes
Given about 2 in 5 American adults are obese, curbing this chronic medical condition could have dramatic effects in decreasing the incidence of cancer
And research is exploring its potential benefits beyond diabetes and weight loss
Rachdi, L
PMID 20303587
US$ 27.15
US$ 26.27
US$ 28.87
:format(webp))
US$ 26.77
US$ 25.27
US$ 22.89
